Sunil Healthcare Limited

Equities

SUNLOC6

INE671C01016

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:58 2024-07-16 am EDT 5-day change 1st Jan Change
87.39 INR -3.91% Intraday chart for Sunil Healthcare Limited -10.88% +59.44%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
CARE Keeps BBB- Rating on Sunil Healthcare's Long-term Bank Financing; Revises Outlook to Negative MT
Sunil Healthcare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Sunil Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Sunil Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Sunil Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
CARE Lowers Rating on Sunil Healthcare's Long-term Bank Financing to BBB-; Revises Outlook to Negative MT
Sunil Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
CARE Affirms BBB Rating on Sunil Healthcare's Long-Term Bank Financing; Revises Outlook to Negative MT
Sunil Healthcare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Sunil Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Sunil Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Sunil Healthcare Limited Announces Company Secretary and Compliance Officer Changes CI
Sunil Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Sunil Healthcare Limited Announces Change in Designation of Sanjay Kumar Kaushik from Independent Director to Non-Executive Director CI
Sunil Healthcare Limited Announces Resignation of Santosh Kumar Sharma as Company Secretary & Compliance Officer CI
Sunil Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
CARE Improves Rating Rating on Sunil Healthcare's Bank Financing to BBB; Outlook Stable MT
Sunil Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Sunil Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Sunil Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Sunil Healthcare Limited Approves Expansion of Installed Production Capacity of Empty Hard Capsule Shell CI
Sunil Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Sunil Healthcare Limited Expands Production Capacity of Empty Hard Capsule Shell CI
Sunil Healthcare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Sunil Healthcare Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Chart Sunil Healthcare Limited
More charts
Sunil Healthcare Limited is an India-based company, which is engaged in manufacturing hard shell capsules. The Company manufactures empty hard gelatin, hydroxypropyl methylcellulose (HPMC) capsule shells and ayurvedic medicines. The Company offers various capsules, including BSE/TSE Free Capsules, Pearl Capsules, Liquid Fill Capsules, Stick Free Capsules, Flavored Capsules, SLS Free Capsules, Natural Color Capsules, Non-Azo Capsules and Preservative Free Capsules. Its hard gelatin capsule shells are available in nine sizes, such as 00, 0SEL, 0EL, 0,1,2,3, 4, 5. Pullulan Capsules these are the type of vegetable capsules made from pullulan. The Vegetable Capsules are commonly used as an option to gelatin because of its vegetarian source and its physical appearance to gelatin. The Company offers empty gelatin capsules that are flavorless, unscented, and colorless, making them simple to consume. Its product range caters to pharma and food supplement industry.
More about the company
  1. Stock Market
  2. Equities
  3. SUNLOC6 Stock
  4. News Sunil Healthcare Limited
  5. CARE Keeps BBB- Rating on Sunil Healthcare's Long-term Bank Financing; Revises Outlook to Negative